Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

2.

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

3.

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

4.

Belzutifan Plus Pembro Approved for Adjuvant RCC

5.

investigating radiation oncology applications of artificial general intelligence.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot